Adaptive immunity maintains occult cancer in an equilibrium state. - Wikidata - wikimedia - TriplyDB

Adaptive immunity maintains occult cancer in an equilibrium state.

Adaptive immunity maintains occult cancer in an equilibrium state.

http://www.wikidata.org/entity/Q46891052

about

Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Epigenetic principles and mechanisms underlying nervous system functions in health and disease Harnessing the immune system to improve cancer therapy Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis Cancer stem cells and immunoresistance: clinical implications and solutions The urgent need to recover MHC class I in cancers for effective immunotherapy A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State Curcumin and tumor immune-editing: resurrecting the immune system Vascular normalization and cancer immunotherapy Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression Novel immunotherapies for hematologic malignancies Metastatic mechanisms in follicular cell-derived thyroid cancer The role and regulation of human Th17 cells in tumor immunity Characteristics of tertiary lymphoid structures in primary cancers Inflammatory networks and immune surveillance of pancreatic carcinoma Combining radiotherapy and cancer immunotherapy: a paradigm shift Bone specific immunity and its impact on metastasis Review of tumor dormancy therapy using traditional oriental herbal medicine Suppression, subversion and escape: the role of regulatory T cells in cancer progression Mechanisms of disseminated cancer cell dormancy: an awakening field Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies Stimulating antitumor immunity with nanoparticles IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse Natural killer cells in human cancer: from biological functions to clinical applications Immunity, Inflammation, and Cancer From mice to humans: developments in cancer immunoediting Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy Type I interferon is selectively required by dendritic cells for immune rejection of tumors Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells Correcting systemic deficiencies in our scientific infrastructure Anti-tumor immunity: myeloid leukocytes control the immune landscape Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors Can we negotiate with a tumor?Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways Cancer: evolutionary, genetic and epigenetic aspects

P2860

Q21195742-3FFCD222-0D74-4357-8827-FE6CAA98216F Q24625197-30487523-D3BD-4A19-890A-8C43D0A1E79D Q24630221-9D0E71A1-C449-465D-A3A0-B48383DD88D5 Q24657549-C5315975-3BF9-4171-B618-68DE2F5B5D22 Q26738698-807AEE32-770E-48B9-9A56-CADDFC555B9A Q26742047-68BE8CE0-AAC8-4AB5-B3D8-B80B9A9058F2 Q26750868-26CF8B1C-CC8C-4FF2-AA05-F21839E3DC83 Q26769757-61A1F04C-943D-40AF-A1E5-2B2B99E219B1 Q26770165-25B4C580-84C7-41E9-B038-951D8E677474 Q26780141-54DC8CB6-D85B-4148-B8CB-9EAB3DDE2107 Q26782573-0D6BCA50-F2CB-4A42-8F58-E7C74E1C0621 Q26783491-47535362-D86B-486D-88BB-D2198586FE31 Q26827437-F716E615-9219-4F96-BF72-128A42088110 Q26829949-CB63D3EB-A5D2-4AFE-B266-B1E4B03F6CB1 Q27004436-9AB4D2B9-18C3-4A5C-AC6F-7B62461D04F0 Q27005646-E56D6004-3919-474D-A184-3B29FE7AC3E3 Q27011396-9CB5F5EA-D2C0-4471-8A9B-7B9B0C7F0AFB Q27012852-EFA4B8E7-5746-4C3B-B524-421097D43654 Q27013983-AF220725-2C8B-4697-BA5B-0C03893B4DE9 Q27021428-EDD55848-DB05-4D99-ADAF-22FEA7ED74C6 Q27022883-15458016-DF8B-439B-99EF-B0FBF474F74B Q27025327-D4500348-956D-49F3-BF8C-577597222FDA Q27026151-7C898D25-752A-4CA8-B868-E9496722B248 Q27027015-03BE5F3E-E30F-4D6C-8073-91626021EBB0 Q27027093-FBDF5CDD-73EA-41D0-A289-EFA7B6CF0068 Q27027243-9B10ED73-151B-44DD-A7E3-9E3910996CC2 Q27027780-A37CE19E-83DD-4AEC-AD7E-1264A6DBDCD0 Q27342843-DAD6FC7D-CEDD-4DA5-9604-BBC0CA1CE361 Q27691427-886A9FC5-AD0D-4EBC-8D81-66DA210235EC Q27861048-AAC91F47-68B3-4E4F-A92E-E843CE207CC1 Q28088304-D09FEA1E-FFBA-4B5F-8987-3C309EB005F5 Q28235277-ED8CF52A-4C36-4F5D-91ED-908CCF76328A Q28248500-549853A1-F66B-4491-B809-B2C70B585FB9 Q28256749-CEDEC2CA-76AB-471B-9EAA-1D0AC1C4097F Q28386804-9BE9D329-058E-49F9-A7A1-17FC9151AD3F Q28390573-A898C9C7-6B15-46D5-ABA6-2C055E2E2975 Q28395507-27E9D0B3-958A-45DF-9BC5-E4C3FB571E8D Q28541524-A4EBE52D-8766-4034-A1DC-DA5AC80C2C1B Q28547655-FB62D53B-70F9-45B5-9B50-8C9BCA178965 Q28728960-A048226D-20BD-4EC0-AC5E-193399FEA469

P2860

Adaptive immunity maintains occult cancer in an equilibrium state.

http://www.wikidata.org/entity/Q46891052

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Adaptive immunity maintains occult cancer in an equilibrium state.

@en

Adaptive immunity maintains occult cancer in an equilibrium state.

@nl

type

label

Adaptive immunity maintains occult cancer in an equilibrium state.

@en

Adaptive immunity maintains occult cancer in an equilibrium state.

@nl

prefLabel

Adaptive immunity maintains occult cancer in an equilibrium state.

@en

Adaptive immunity maintains occult cancer in an equilibrium state.

@nl

P1433

Q46891052-6A05C116-45C1-4C1B-829A-DAAB34AD81AF

P1476

Q46891052-660DAF62-D5E3-4CA2-8726-C3495C8521C8

P2093

Q46891052-4814DAA1-6B60-4C3D-AD45-D483CF0B2948

Q46891052-4CEE57FE-DD1E-4EDE-8D48-06ED230A550A

Q46891052-81989F5D-4EF0-4B81-9F93-78F1F6B9CEFB

Q46891052-AB198544-F249-4DFB-A89B-A7A4E006C69B

Q46891052-DCF20358-EFB1-4C85-949B-AF94FA2BDED8

Q46891052-E2A5B80E-3989-4CC0-BBAC-8B4855AE3144

P2888

Q46891052-3679DAB9-886C-4816-B300-7A31ABA0E527

P304

Q46891052-C4750353-C30A-41A1-8706-0CBF47CBD604

P31

Q46891052-CF9ADE91-5E63-424E-8C26-1A76D4D71EED

P356

Q46891052-29A23AD9-F690-452B-AFBE-F49AAEE41383

P407

Q46891052-7D854C3C-07EC-4873-B517-9ED629FA68B2

P433

Q46891052-0F6147DF-7219-4ACB-8E03-62096DADDC90

P478

Q46891052-6357D9AC-D90B-40AA-94AB-338C97B9008D

P50

Q46891052-16906FDE-31D4-4939-987E-4101589F31D4

Q46891052-C6541001-DFB1-4758-86AE-95FDAA50A85A

P577

Q46891052-E4667700-3434-43EE-99A7-BABA878E98FB

P5875

Q46891052-DF380787-1DAD-4881-AB4D-17ED0F7F9A5B

P6179

Q46891052-BF8957C1-6BC2-4FC6-B333-C119B49A1F15

P698

Q46891052-2DB18981-8B89-4554-BA2E-4A242368E199

P356

P1433

P1476

Adaptive immunity maintains occult cancer in an equilibrium state.

@en

P2093

Catherine M Koebel

http://www.w3.org/2001/XMLSchema#string

Jeremy B Swann

http://www.w3.org/2001/XMLSchema#string

Lloyd J Old

http://www.w3.org/2001/XMLSchema#string

Nadeen Zerafa

http://www.w3.org/2001/XMLSchema#string

Robert D Schreiber

http://www.w3.org/2001/XMLSchema#string

Scott J Rodig

http://www.w3.org/2001/XMLSchema#string

P2888

P304

903-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE06309

http://www.w3.org/2001/XMLSchema#string

P407

P433

7171

http://www.w3.org/2001/XMLSchema#string

P478

450

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5821327

http://www.w3.org/2001/XMLSchema#string

P6179

1000116337

http://www.w3.org/2001/XMLSchema#string

P698

18026089

http://www.w3.org/2001/XMLSchema#string